Work

Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203)

Year: 2020

Type: article

Source: Neurology

DOI: 10.1212/wnl.94.15_supplement.1203

Authors: Messoud Ashina, Peter Goadsby, Uwe Reuter, Stephen Silberstein, David Dodick, Fei Xue, Feng Zhang, Sunfa Cheng, Daniel Mikol

Institutions: University of California, San Francisco, Charité – Universitätsmedizin Berlin, Mayo Clinic in Arizona, Amgen (United States)

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3093745937

FWCI: 1.099

Cites:

Cited by: 7

Related to: 10